Clozapine-d8是Clozapine的氘代同位素化合物。Clozapine 是一种抗精神病药物,具有高效结合多种神经受体的能力,广泛用于精神分裂症的研究。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | D1 receptor ↓ ↑ | D2 receptor ↓ ↑ | D3 receptor ↓ ↑ | D4 receptor ↓ ↑ | D5 receptor ↓ ↑ | DAT ↓ ↑ | Dopamine receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Penfluridol |
+
Dopamine receptor, Ki: 1.6 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ansofaxine HCl |
++
Dopamine receptor, IC50: 491 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Tetrahydroberberine,THB |
+
D2 receptor, pKi: 6.08 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Prochlorperazine Maleate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Olanzapine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Trifluoperazine |
++++
Dopamine D2 receptor, IC50: 1.1 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ropinirole hydrochloride |
++
D2 receptor, Ki: 29 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Lurasidone |
++++
D2 receptor, Ki: 1 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Levosulpiride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pridopidine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Metoclopramide | ✔ | ✔ | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Molindone HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Sulpiride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Perospirone |
++++
D2 receptor, Ki: 1.4 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Perospirone HCl |
++++
D2 receptor, Ki: 1.4 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Phenothiazine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pimozide |
+
Dopamine D1 receptor, Ki: 6600 nM |
+++
Dopamine D2 receptor, Ki: 3.0 nM |
++++
Dopamine D3 receptor, Ki: 0.83 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
Rotundine |
++
D1 receptor, IC50: 166 nM |
+
D2 receptor, IC50: 1.47 μM |
+
D3 receptor, IC50: 3.25 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
Domperidone | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
ONC206 | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pimethixene maleate |
++
Dopamine D1 Receptor, pKi: 6.37 |
+++
Dopamine D2 Receptor, pKi: 8.19 |
++
Dopamine D4.4 Receptor, pKi: 7.54 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
Loxapine succinate |
++
D2 receptor (Human), Ki: 62 nM D1 receptor (human), Ki: 26 nM |
++
D2 receptor (human), Ki: 24 nM D2 receptor (bovine), Ki: 26 nM |
+++
D4 receptor (human), Ki: 7.5 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||
Chlorprothixene |
+++
D1 receptor, Ki: 18 nM |
+++
D2 receptor, Ki: 2.96 nM |
+++
D3 receptor, Ki: 4.56 nM |
+++
D5 receptor, Ki: 9 nM |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||
SCH-23390 HCl |
++++
D1 dopamine receptor, Ki: 0.2 nM |
++++
D5 dopamine receptor, Ki: 0.3 nM |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||||
MPP+ iodide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
σ1 Receptor antagonist-1 |
+
DAT, pKi: 5.8 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Benztropine mesylate |
++
DAT, IC50: 118 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Azaperone | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ziprasidone HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Paliperidone | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Alizapride HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Amisulpride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Quetiapine hemifumarate | ✔ | Adrenergic Receptor | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Clozapine N-oxide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | Adrenergic Receptor ↓ ↑ | α-adrenergic receptor ↓ ↑ | β-adrenergic receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivabradine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Maprotiline hydrochloride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Cisatracurium besylate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Yohimbine HCI | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
BMY 7378 |
++
α1D-adrenoceptor, pKi: 5.1 α2C-adrenoceptor, pKi: 6.54 |
+
β1-adrenoceptor, pIC50: 5.1 |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Asenapine maleate |
++++
α2A-adrenergic receptor, pKi: 8.9 α2B-adrenergic receptor, pKi: 8.9 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Piribedil |
++
adrenoceptor α2A, pKi: 7.1 adrenoceptor α2C, pKi: 7.2 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Prazosin HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Silodosin | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Phenoxybenzamine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Naftopidil |
+++
α1A-adrenergic receptor, Ki: 3.7 nM α1D-adrenergic receptor, Ki: 20 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Naftopidil 2HCl |
+
α1-adrenergic receptor, IC50: 0.2 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Alfuzosin HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Terazosin HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Atipamezole | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Phentolamine methanesulfonate salt | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Doxazosin mesylate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Tolazoline HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Zenidolol hydrochloride |
++++
β1-adrenergic receptor, Ki: 611nM β2-adrenergic receptor, Ki: 0.7nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | 5-HT ↓ ↑ | 5-HT1 ↓ ↑ | 5-HT2 ↓ ↑ | 5-HT3 ↓ ↑ | 5-HT5 ↓ ↑ | 5-HT6 ↓ ↑ | 5-HT7 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Desvenlafaxine |
++
5-HT, Ki: 40.2 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Lamotrigine |
+
5-HT (rat brain synaptosomes), IC50: 474 μM 5-HT (human platelets), IC50: 240 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Venlafaxine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Fluvoxamine maleate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Iloperidone | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ziprasidone HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Atomoxetine HCI |
+
5-HT, Ki: 77 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Dapoxetine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Trazodone | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Clomipramine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Mirtazapine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Escitalopram oxalate |
+++
5-HT, Ki: 0.89 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Duloxetine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Sertraline HCl |
++
5-HT, Ki: 13 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Citalopram HBr |
+++
serotonin reuptake, IC50: 1.8 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Latrepirdine 2HCl | ✔ | GluR | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Fluoxetine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Paroxetine hydrochloride | ✔ | AChR | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
BMY 7378 |
++
5-HT1D, pIC50: 5.9 5-HT1A, pIC50: 6.4 |
+
5-HT2, pIC50: 5.5 |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Flibanserin |
+++
5-HT1A, Ki: 1 nM |
+
5-HT2A, Ki: 49 nM |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||||
LY310762 |
+
5-HT1D, Ki: 249 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Cyclobenzaprine HCI | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Blonanserin |
+++
5-HT2, Ki: 3.98 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Cyproheptadine HCl |
++++
5-HT2, IC50: 0.6 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Olanzapine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pimavanserin hemitartrate |
+++
5-HT2A, pIC50: 8.7 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ketanserin |
+++
5-HT2C (Rat), Ki: 50 nM 5-HT2C (Human), Ki: 2.5 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Loxapine succinate |
++
5-HT2 (human), Ki: 6.8 nM 5-HT2 (bovine), Ki: 6.6 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Agomelatine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Clozapine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Amitriptyline |
+
5-HT2, Ki: 235 nM |
SERT | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
PRX-08066 maleate |
+++
5-HT2B, IC50: 3.4 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
RS-127445 |
++++
5-HT2B, pIC50: 10.4 5-HT2B, pKi: 9.5 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Sarpogrelate HCl |
++++
5-HT2C, Kd: 1.1 nM 5-HT2A, Kd: 2.1 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Tropisetron | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Palonosetron | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ramosetron HCl |
++++
5-HT3 receptor, Ki: 0.091 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ondansetron | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Granisetron | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Alosetron HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ondansetron hydrochloride dihydrate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
VUF10166 |
++++
5-HT3AB, Ki: 22 nM 5-HT3A, Ki: 0.04 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Azasetron hydrochloride |
++++
5-HT3, IC50: 0.33 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Asenapine maleate |
+++
5-HT1A, pKi: 8.6 5-HT1B, pKi: 8.4 |
++++
5-HT2C, pKi: 10.46 5-HT2A, pKi: 9.75 |
+++
5-HT5A, pKi: 8.84 |
++++
5-HT6, pKi: 9.6 |
++++
5-HT7, pKi: 9.94 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||
Risperidone |
++
5-HT1D, Ki: 84.6 nM 5-HT1B, Ki: 14.9 nM |
++++
5-HT2C, Ki: 12 nM 5-HT2A, Ki: 61.9 nM |
+
5-HT5A, Ki: 206 nM |
++
5-HT7, Ki: 6.6 nM |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||
SB 271046 HCl |
+++
5-HT6, pKi: 8.92 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Intepirdine |
++++
5-HT6, pKi: 9.63 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
SB-269970 HCl |
++
5-HT7, pKi: 8.3 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
BRL 15572 |
++
5-HT1D, pKi: 6 5-HT1B, pKi: 6.1 |
++
5-HT2A, pKi: 6.6 5-HT2B, pKi: 6.2 |
+
5-HT6, pKi: 5.9 |
+
5-HT7, pKi: 6.3 |
{[allProObj[0].p_purity_real_show]} | ||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | AChE ↓ ↑ | AChR ↓ ↑ | mAChR ↓ ↑ | nAChR ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Donepezil |
+++
hAChE, IC50: 11.6 nM bAChE, IC50: 8.12 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Loganin |
++
AChE, IC50: 3.95 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
topride HCl |
++
AChE, IC50: 2.04 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Dehydroevodiamine HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Jatrorrhizine |
++
AChE, IC50: 872 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Palmatine |
++
AChE, IC50: 0.51 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
(-)-Huperzine A |
++++
AChE (G4 form), Ki: 7 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Galanthamine HBr |
++
AChE, IC50: 0.35 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Trospium chloride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Tiotropium Bromide Monohydrate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Gallamine Triethiodide |
+
AChR, IC50: 68.0 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Hexamethonium Bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pancuronium dibromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Neostigmine bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Orphenadrine citrate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Oxybutynin | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Irsogladine | ✔ | PDE | {[allProObj[0].p_purity_real_show]} | ||||||||||||||||
Pyridostigmine bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Rivastigmine |
+
AChR, IC50: 5.5 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Paroxetine hydrochloride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Rocuronium Bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Tropicamide |
+++
M4 mAChR, IC50: 8 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Diphenmanil methylsulfate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Umeclidinium bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Otilonium bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Flavoxate HCl |
+
mAChR, IC50: 12.2 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Ipratropium bromide | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Diphenidol HCl | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Darifenacin hydrobromide |
++++
M3 mAChR, pKi: 8.9 |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Aclidinium Bromide |
++++
M4 mAChR, Ki: 0.21 nM M2 mAChR, Ki: 0.1 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Oxybutynin chloride | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Pentoxyverine citrate | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Solifenacin | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Catharanthine | ✔ | {[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Benzethonium chloride |
+++
α4β2 nAChRs, IC50: 49 nM α7 nAChRs, IC50: 122 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
Vinblastine sulfate |
+
nAChR, IC50: 8.9 μM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
PNU-120596 |
++
α7 nAChR, EC50: 216 nM |
{[allProObj[0].p_purity_real_show]} | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.99mL 0.60mL 0.30mL |
14.93mL 2.99mL 1.49mL |
29.86mL 5.97mL 2.99mL |
CAS号 | 1185053-50-2 |
分子式 | C18H19ClN4 |
分子量 | 334.873 |
别名 | HF 1854-d8 |
运输 | 蓝冰 |
存储条件 |
粉末 Keep in dark place,Inert atmosphere,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
溶解度 | |
动物实验配方 |